noting special is a juts lancet that we already know no pattern and no nevus stock will still go low if the pattern dont come before the 13 the stock will crush after the Earnings and i assume that, to find a pattern or buyout will take time and time! we may see $19, today.
the only thing that doesn't look to good is the possibility that they let u graduate HS...funny thing is you're probably short here a few hundred shares, while many of us here are long 1000's of shares and would still make money @ 3.10!!...i would say u may win the near battles but the war will be won by us!! go away now like so many before and after you...Happy Halloween
acad Is so much different than dndn. dndn transfusion was good for only 3.5 months median survival at $93000 a clip, not really worth the coast for so little survival, not to mention newer more effective treatments that have been developed since then.acad has no competition, and will be first in class for several indications.